tetano
Editor, Senior Moderator
PLoS Pathog
. 2023 Apr 17;19(4):e1010943.
doi: 10.1371/journal.ppat.1010943. Online ahead of print.
Maximal interferon induction by influenza lacking NS1 is infrequent owing to requirements for replication and export
Alison C Vicary[SUP] 1 [/SUP], Marisa Mendes[SUP] 1 [/SUP], Sharmada Swaminath[SUP] 1 [/SUP], Asama Lekbua[SUP] 1 [/SUP], Jack Reddan[SUP] 1 [/SUP], Zaida K Rodriguez[SUP] 1 [/SUP], Alistair B Russell[SUP] 1 [/SUP]
Affiliations
Abstract
Influenza A virus exhibits high rates of replicative failure due to a variety of genetic defects. Most influenza virions cannot, when acting as individual particles, complete the entire viral life cycle. Nevertheless influenza is incredibly successful in the suppression of innate immune detection and the production of interferons, remaining undetected in >99% of cells in tissue-culture models of infection. Notably, the same variation that leads to replication failure can, by chance, inactivate the major innate immune antagonist in influenza A virus, NS1. What explains the observed rarity of interferon production in spite of the frequent loss of this, critical, antagonist? By studying how genetic and phenotypic variation in a viral population lacking NS1 correlates with interferon production, we have built a model of the "worst-case" failure from an improved understanding of the steps at which NS1 acts in the viral life cycle to prevent the triggering of an innate immune response. In doing so, we find that NS1 prevents the detection of de novo innate immune ligands, defective viral genomes, and viral export from the nucleus, although only generation of de novo ligands appears absolutely required for enhanced detection of virus in the absence of NS1. Due to this, the highest frequency of interferon production we observe (97% of infected cells) requires a high level of replication in the presence of defective viral genomes with NS1 bearing an inactivating mutation that does not impact its partner encoded on the same segment, NEP. This is incredibly unlikely to occur given the standard variation found within a viral population, and would generally require direct, artificial, intervention to achieve at an appreciable rate. Thus from our study, we procure at least a partial explanation for the seeming contradiction between high rates of replicative failure and the rarity of the interferon response to influenza infection.
. 2023 Apr 17;19(4):e1010943.
doi: 10.1371/journal.ppat.1010943. Online ahead of print.
Maximal interferon induction by influenza lacking NS1 is infrequent owing to requirements for replication and export
Alison C Vicary[SUP] 1 [/SUP], Marisa Mendes[SUP] 1 [/SUP], Sharmada Swaminath[SUP] 1 [/SUP], Asama Lekbua[SUP] 1 [/SUP], Jack Reddan[SUP] 1 [/SUP], Zaida K Rodriguez[SUP] 1 [/SUP], Alistair B Russell[SUP] 1 [/SUP]
Affiliations
- PMID: 37068114
- DOI: 10.1371/journal.ppat.1010943
Abstract
Influenza A virus exhibits high rates of replicative failure due to a variety of genetic defects. Most influenza virions cannot, when acting as individual particles, complete the entire viral life cycle. Nevertheless influenza is incredibly successful in the suppression of innate immune detection and the production of interferons, remaining undetected in >99% of cells in tissue-culture models of infection. Notably, the same variation that leads to replication failure can, by chance, inactivate the major innate immune antagonist in influenza A virus, NS1. What explains the observed rarity of interferon production in spite of the frequent loss of this, critical, antagonist? By studying how genetic and phenotypic variation in a viral population lacking NS1 correlates with interferon production, we have built a model of the "worst-case" failure from an improved understanding of the steps at which NS1 acts in the viral life cycle to prevent the triggering of an innate immune response. In doing so, we find that NS1 prevents the detection of de novo innate immune ligands, defective viral genomes, and viral export from the nucleus, although only generation of de novo ligands appears absolutely required for enhanced detection of virus in the absence of NS1. Due to this, the highest frequency of interferon production we observe (97% of infected cells) requires a high level of replication in the presence of defective viral genomes with NS1 bearing an inactivating mutation that does not impact its partner encoded on the same segment, NEP. This is incredibly unlikely to occur given the standard variation found within a viral population, and would generally require direct, artificial, intervention to achieve at an appreciable rate. Thus from our study, we procure at least a partial explanation for the seeming contradiction between high rates of replicative failure and the rarity of the interferon response to influenza infection.